Literature DB >> 4568014

Virginiamycin: nomenclature.

P Crooy, R De Neys.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4568014     DOI： 10.7164/antibiotics.25.371

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  7 in total

Review 1.  Antibiotics of the virginiamycin family, inhibitors which contain synergistic components.

Authors:  C Cocito
Journal:  Microbiol Rev       Date:  1979-06

2.  The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits.

Authors:  C Cocito; M Di Giambattista
Journal:  Mol Gen Genet       Date:  1978-10-25

3.  In vitro evaluation of ramoplanin (MDL 62198, A 16686)

Authors:  S Dixson; W Brumfitt; J M Hamilton-Miller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

4.  The conformational flexibility of the antibiotic virginiamycin M(1).

Authors:  Jason Dang; Robert P Metzger; Robert T C Brownlee; Chai Ann Ng; Mikael Bergdahl; Frances Separovic
Journal:  Eur Biophys J       Date:  2005-04-15       Impact factor: 1.733

5.  A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes.

Authors:  R Parfait; M P de Béthune; C Cocito
Journal:  Mol Gen Genet       Date:  1978-10-25

6.  Purification of peptide synthetases involved in pristinamycin I biosynthesis.

Authors:  D Thibaut; D Bisch; N Ratet; L Maton; M Couder; L Debussche; F Blanche
Journal:  J Bacteriol       Date:  1997-02       Impact factor: 3.490

7.  Purification of the two-enzyme system catalyzing the oxidation of the D-proline residue of pristinamycin IIB during the last step of pristinamycin IIA biosynthesis.

Authors:  D Thibaut; N Ratet; D Bisch; D Faucher; L Debussche; F Blanche
Journal:  J Bacteriol       Date:  1995-09       Impact factor: 3.490
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.